The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...
Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...
While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...
With thousands of lawsuits and growing concerns over long-term risks, the FDA have added a brain tumor warning to the drug's label.
The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more ...
The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.
Between condoms and vasectomies lies a vast, undeveloped chasm of male birth control. Contraline, a device startup that released early, positive clinical data in a press release on Thursday, hopes to ...
When it comes to their sexual health, what women don’t know can hurt them. But University Health Center officials are trying to help women improve their health by educating them about birth control ...
The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...
The judge appointed Chris Seeger as lead counsel and co-leads Ellen Relkin and Bryan Aylstock. More than 70 lawsuits against Pfizer allege Depo-Provera, an injectable birth control, has been linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results